NASDAQ:AMGN • US0311621009
This AMGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 5 out of 10 to AMGN. AMGN was compared to 519 industry peers in the Biotechnology industry. AMGN scores excellent on profitability, but there are concerns on its financial health. AMGN has a correct valuation and a medium growth rate. AMGN also has an excellent dividend rating.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROIC | 16.85% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.83 | ||
| Fwd PE | 16.11 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.48 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.74% |
367.79
-9.85 (-2.61%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.74% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.83 | ||
| Fwd PE | 16.11 | ||
| P/S | 5.39 | ||
| P/FCF | 24.48 | ||
| P/OCF | 19.91 | ||
| P/B | 22.9 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 89.06% | ||
| ROCE | 19.3% | ||
| ROIC | 16.85% | ||
| ROICexc | 19.6% | ||
| ROICexgc | 73.08% | ||
| OM | 34.19% | ||
| PM (TTM) | 20.98% | ||
| GM | 73.3% | ||
| FCFM | 22.04% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.78 | ||
| Debt/FCF | 6.74 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 5.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 105.05% | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | N/A |
ChartMill assigns a fundamental rating of 5 / 10 to AMGN.
ChartMill assigns a valuation rating of 5 / 10 to AMGEN INC (AMGN). This can be considered as Fairly Valued.
AMGEN INC (AMGN) has a profitability rating of 8 / 10.
The financial health rating of AMGEN INC (AMGN) is 3 / 10.
The Earnings per Share (EPS) of AMGEN INC (AMGN) is expected to grow by 4.46% in the next year.